Henry F. Blissenbach
Nessuna posizione attualmente
Profilo
Henry F.
Blissenbach, serves as a Director, President and Chief Executive Officer for BioScrip Inc. Dr. Blissenbach was named to this position upon the consummation of the merger between MIM Corporation and Chronimed, Inc. effective March 2005.
Dr. Blissenbach previously served as Chairman and Chief Executive Officer of Chronimed, Inc. He was appointed Chairman of the Board of Directors and Chief Executive Officer of Chronimed on July 1, 2000.
Dr. Blissenbach was named President and Chief Operating Officer of Chronimed in May 1997.
He became a director of Chronimed in September 1995.
From 1992 to 1997, he served as President of Diversified Pharmaceutical Services, Inc., a UnitedHealthcare subsidiary until 1994 and afterwards a subsidiary of SmithKline Beecham Corp.
Diversified Pharmaceutical Services, Inc. was a pharmacy benefit management firm.
Dr. Blissenbach also serves as a director of Ligand Pharmaceuticals Inc., a publicly held biopharmaceutical development company, and Opportunity Partners, Inc., a nonprofit company.
Precedenti posizioni note di Henry F. Blissenbach
Società | Posizione | Fine |
---|---|---|
Chronimed, Inc.
Chronimed, Inc. Medical DistributorsDistribution Services Chronimed, Inc. develops, markets and distributes pharmaceuticals, general medical products and patient education materials directly to the individual and to the patients of managed care and case management companies nationwide, as well as to the institutions that serve these patients. It was founded in 1985 and is headquartered in Minnetonka, MN. | Presidente | 09/08/2004 |
BioScrip, Inc.
BioScrip, Inc. Managed Health CareHealth Services BioScrip, Inc. engages in the provision of home infusion and home care management solutions. It partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. The company was founded in 1996 and is headquartered in Denver, CO. | Presidente | - |
LIGAND PHARMACEUTICALS INCORPORATED | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
Aziende private | 2 |
---|---|
Chronimed, Inc.
Chronimed, Inc. Medical DistributorsDistribution Services Chronimed, Inc. develops, markets and distributes pharmaceuticals, general medical products and patient education materials directly to the individual and to the patients of managed care and case management companies nationwide, as well as to the institutions that serve these patients. It was founded in 1985 and is headquartered in Minnetonka, MN. | Distribution Services |
BioScrip, Inc.
BioScrip, Inc. Managed Health CareHealth Services BioScrip, Inc. engages in the provision of home infusion and home care management solutions. It partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. The company was founded in 1996 and is headquartered in Denver, CO. | Health Services |
- Borsa valori
- Insiders
- Henry F. Blissenbach